Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

This study is currently recruiting participants.
Verified March 2013 by Immunomedics, Inc.
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT00547066
First received: October 17, 2007
Last updated: March 25, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
No publications provided by Immunomedics, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):